Mapping the Complexity of End of Life Transitions in Chronically Critically Ill

绘制慢性危重病患者临终过渡的复杂性

基本信息

  • 批准号:
    8339892
  • 负责人:
  • 金额:
    $ 40.63万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-09-27 至 2014-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): There is strong national consensus about the pressing need to improve the delivery of end of life (EOL) care in the ICU. Despite decades of study and tests of interventions targeting specific elements, there continue to be concerns about prolonged use of ineffective therapies, resulting in suffering of both patients and families, as wel as moral distress of clinicians. The situation of chronically critically ill patients (CCI), with te complex interface of acute-on-chronic conditions and uncertain prognoses, presents particular challenges to clinicians and family surrogates in attempting to assess treatment effectiveness and identify the appropriate criteria and time for transitioning to a focus on palliation and EOL measures. While there is a growing body of work examining factors that influence decision making, the challenges faced by families and clinicians caring for CCI patients have been somewhat resistant to major improvements. Pre-existing clinician and family characteristics and philosophies (religious, cultural, personal), actual clinical trajectory of patient condition, expectations of likely outcomes, and evaluation of the effectiveness of treatment have all been shown to be relevant to decision making patterns. However, major intervention trials have failed to demonstrate significant gains. Previous studies have focused on a limited number of components or participants, using hypothetical scenarios or retrospective reports. In contrast, we will follow the natural trajectory of illness and decision making, which will allow us to examine the decision making system and factors influencing transitions or the lack of transitions from cure-oriented therapies to palliative and EOL interventions in the CCI. The proposed investigation will shift the current research paradigm in being the first to apply the principles o complexity science in examining how factors that influence transitions in actual practice interact. This will allow us to detect changes over time, and to account for relationships among various elements, such as religious beliefs of family surrogates, patient characteristics, and salient clue used by clinicians to trigger changes in goals. This will yield both a more accurate understanding of the phenomenon of transitions in the care of CCI, as well as new targets for intervention and guidance for tailored approaches. The primary aims are: (1) Examine the extent to which transitions to EOL care are predicted indirectly by characteristics (patient, clinician, family) and clinical triggers, and directly by outcome expectations (MD, family) and evaluation of treatment effectiveness; (2) Examine the extent to which evaluation of treatment effectiveness is predicted by characteristics (patient, clinician), outcome expectations (MD, family), and clinical triggers; (3) Examine the extent to which physician outcome expectations (survival, functional status, health related quality of life [HRQOL]) are predicted by physician characteristics, patient characteristics, and clinical triggers; (4) Examine the extent to which family outcome expectations (survival, functional status, HRQOL) are predicted by physician outcome expectations, family characteristics, and patient characteristics.
描述(由申请人提供):对于改善 ICU 临终 (EOL) 护理服务的迫切需要,全国达成了强烈共识。尽管针对特定因素的干预措施进行了数十年的研究和测试,但人们仍然担心长期使用无效的疗法,导致患者和家庭的痛苦,以及临床医生的道德困境。慢性危重症患者 (CCI) 的情况,慢性病急性发作的复杂界面和不确定的预后,对临床医生和家庭代理人在试图评估治疗效果并确定适当的标准和过渡时间时提出了特殊的挑战。重点关注姑息治疗和 EOL 措施。尽管越来越多的工作正在研究影响决策的因素,但照顾 CCI 患者的家庭和临床医生所面临的挑战在一定程度上阻碍了重大改进。已有的临床医生和家庭特征以及哲学(宗教、文化、个人)、患者病情的实际临床轨迹、对可能结果的期望以及对治疗有效性的评估都已被证明与决策模式相关。然而,主要的干预试验未能显示出显着的效果。 以前的研究使用假设情景或回顾性报告,重点关注有限数量的组成部分或参与者。相比之下,我们将遵循疾病和决策的自然轨迹,这将使我们能够检查决策系统和影响 CCI 中从以治愈为导向的治疗到姑息治疗和 EOL 干预的过渡或缺乏过渡的因素。拟议的调查将改变当前的研究范式,成为第一个应用复杂性科学原理来研究影响实际实践中转变的因素如何相互作用的研究范式。 这将使我们能够检测随着时间的推移发生的变化,并解释各种因素之间的关系,例如家庭代理人的宗教信仰、患者特征以及临床医生用来触发目标变化的显着线索。这将使人们更准确地了解 CCI 护理中的转变现象,并为干预措施和定制方法提供新的指导。主要目标是:(1)检查通过特征(患者、临床医生、家庭)和临床触发因素间接预测向 EOL 护理过渡的程度,以及通过结果预期(医学博士、家庭)和治疗效果评估直接预测的程度; (2) 检查根据特征(患者、临床医生)、结果预期(MD、家庭)和临床触发因素预测治疗效果评估的程度; (3) 检查医生特征、患者特征和临床触发因素预测医生结果预期(生存、功能状态、健康相关生活质量 [HRQOL])的程度; (4) 检查医生结果预期、家庭特征和患者特征对家庭结果预期(生存、功能状态、HRQOL)的预测程度。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The Accuracy of Nurses' Predictions for Clinical Outcomes in the Chronically Critically Ill.
护士对慢性危重病患者临床结果预测的准确性。
Complexity Analysis of Decision-Making in the Critically Ill.
  • DOI:
    10.1177/0885066616678394
  • 发表时间:
    2018-10
  • 期刊:
  • 影响因子:
    3.1
  • 作者:
    Daly BJ;Douglas SL;O'Toole E;Rowbottom J;Hoffer A;Lipson AR;Burant C
  • 通讯作者:
    Burant C
Family and Nurse Prognostication in Chronic Critical Illness.
慢性危重疾病的家庭和护士预测。
Differences in Predictions for Survival and Expectations for Goals of Care between Physicians and Family Surrogate Decision Makers of Chronically Critically Ill Adults.
慢性危重病成人的医生和家庭代理决策者之间对生存的预测和对护理目标的期望存在差异。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Barbara Daly其他文献

Barbara Daly的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Barbara Daly', 18)}}的其他基金

Oncology Nurse IMPACT:Improving Communication with Patients about Clinical Trial
肿瘤科护士影响:改善与患者有关临床试验的沟通
  • 批准号:
    8666900
  • 财政年份:
    2014
  • 资助金额:
    $ 40.63万
  • 项目类别:
Oncology Nurse IMPACT:Improving Communication with Patients about Clinical Trial
肿瘤科护士影响:改善与患者有关临床试验的沟通
  • 批准号:
    8865579
  • 财政年份:
    2014
  • 资助金额:
    $ 40.63万
  • 项目类别:
Symptom Management and Palliative Care Research in Adults with Advanced Disease
成人晚期疾病的症状管理和姑息治疗研究
  • 批准号:
    8472723
  • 财政年份:
    2013
  • 资助金额:
    $ 40.63万
  • 项目类别:
Symptom Management and Palliative Care Research in Adults with Advanced Disease
成人晚期疾病的症状管理和姑息治疗研究
  • 批准号:
    8664939
  • 财政年份:
    2013
  • 资助金额:
    $ 40.63万
  • 项目类别:
Symptom Management and Palliative Care Research in Adults with Advanced Disease
成人晚期疾病的症状管理和姑息治疗研究
  • 批准号:
    8875492
  • 财政年份:
    2013
  • 资助金额:
    $ 40.63万
  • 项目类别:
Symptom Management and Palliative Care Research in Adults with Advanced Disease
成人晚期疾病的症状管理和姑息治疗研究
  • 批准号:
    9098467
  • 财政年份:
    2013
  • 资助金额:
    $ 40.63万
  • 项目类别:
Mapping the Complexity of End of Life Transitions in Chronically Critically Ill
绘制慢性危重病患者临终过渡的复杂性
  • 批准号:
    8255223
  • 财政年份:
    2011
  • 资助金额:
    $ 40.63万
  • 项目类别:
Building End-of-Life Science through Positive Human Strengths and Traits
通过积极的人类优势和特质建立临终科学
  • 批准号:
    7850228
  • 财政年份:
    2009
  • 资助金额:
    $ 40.63万
  • 项目类别:
Building End-of-Life Science through Positive Human Strengths and Traits
通过积极的人类优势和特质建立临终科学
  • 批准号:
    7943968
  • 财政年份:
    2009
  • 资助金额:
    $ 40.63万
  • 项目类别:
Improving The Quality Of Advanced Cancer Care With Disease Management
通过疾病管理提高晚期癌症护理的质量
  • 批准号:
    7492879
  • 财政年份:
    2007
  • 资助金额:
    $ 40.63万
  • 项目类别:

相似国自然基金

SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
  • 批准号:
    82300697
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
Tenascin-X对急性肾损伤血管内皮细胞的保护作用及机制研究
  • 批准号:
    82300764
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
  • 批准号:
    82370084
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
KIF5B调控隧道纳米管介导的线粒体转运对FLT3-ITD阳性急性髓系白血病的作用机制
  • 批准号:
    82370175
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
PHF6突变通过相分离调控YTHDC2-m6A-SREBP2信号轴促进急性T淋巴细胞白血病发生发展的机制研究
  • 批准号:
    82370165
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目

相似海外基金

TIER-PALLIATIVE CARE: A population-based care delivery model to match evolving patient needs and palliative care services for community-based patients with heart failure or cancer
分级姑息治疗:基于人群的护理提供模式,以满足不断变化的患者需求,并为社区心力衰竭或癌症患者提供姑息治疗服务
  • 批准号:
    10880994
  • 财政年份:
    2023
  • 资助金额:
    $ 40.63万
  • 项目类别:
CSRD Research Career Scientist Award Application
CSRD研究职业科学家奖申请
  • 批准号:
    10701136
  • 财政年份:
    2023
  • 资助金额:
    $ 40.63万
  • 项目类别:
Elucidating Non-Routine Events Arising from Interhospital Transfers
阐明院间转移引起的非常规事件
  • 批准号:
    10749448
  • 财政年份:
    2023
  • 资助金额:
    $ 40.63万
  • 项目类别:
Oral Health Utilization and Outcomes Among Patients on Medications for Opioid Use Disorder
阿片类药物使用障碍患者的口腔健康利用和结果
  • 批准号:
    10741957
  • 财政年份:
    2023
  • 资助金额:
    $ 40.63万
  • 项目类别:
Screen Smart: Using Digital Health to Improve HIV Screening and Prevention for Adolescents in the Emergency Department
智能屏幕:利用数字健康改善急诊科青少年的艾滋病毒筛查和预防
  • 批准号:
    10711679
  • 财政年份:
    2023
  • 资助金额:
    $ 40.63万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了